Power Law company profile

OM1

Biotech & Life Sciences · Boston, United States · Founded 2015 Colt

A leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Revenue

$10–50M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

9 investors on OM1's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Wanxiang Healthcare Investments

General Catalyst

7wire Ventures

Series B+ 6 investors entered at this stage

Polaris Partners

Scale Venture Partners

Breyer Capital

D1 Capital Partners

Kaiser Permanente

Glikvest

Global footprint

Where OM1 has talent and traffic

AI talent share

12.5% of workforce is AI talent
(13 of 104 staff)

Core AI32.88%

Other AI109.62%

Non-AI workforce9187.5%

Workforce by country

🇺🇸 United States · Boston HQ

Book a demo for the full country breakdown

Web traffic by country

13K monthly visits
across markets

🇺🇸 United States98.5%

Top 1 markets shown

Market sentiment

What the market is saying about OM1

An AI-synthesized read of the highest-engagement posts about OM1 on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See OM1 on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles